Meeting
2021 ASCO Annual Meeting
Analysis of immune checkpoint blockade biomarkers in elderly patients using large-scale cancer genomics data.
Authors
Rossin Erbe
Johns Hopkins School of Medicine, Baltimore, MD
Rossin Erbe , Zheyu Wang , Sharon Wu , Joanne Xiu , Neeha Zaidi , Marc E. Lippman , Claudine Isaacs , Reva K Basho , Heinz-Josef Lenz , Igor A. Astsaturov , John Marshall , Stephen Baylin , Elizabeth M. Jaffee , Evanthia T. Roussos Torres , Ashani Weeraratna , Hariharan Easwaran , Elana J. Fertig
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Immunobiology
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 2543)
DOI
10.1200/JCO.2021.39.15_suppl.2543
Abstract #
2543
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Genomic landscape and peripheral blood biomarkers of advanced triple-negative breast cancer treated with immune checkpoint blockade: An exploratory analysis of the TQB2450-Ib-07 trial.
First Author: Yiqun Han
Poster
2022 ASCO Genitourinary Cancers Symposium
Tumor genomic landscape in younger compared to older patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC).
First Author: Nishita Tripathi
Poster
2021 Genitourinary Cancers Symposium
CDKN2A alterations as markers of immune checkpoint blockade (ICB) resistance in urothelial carcinoma (UC).
First Author: Amin Nassar
Poster
2019 ASCO Annual Meeting
Real-world experience and molecular features of response to immune checkpoint blockade in patients with recurrent small cell lung cancer.
First Author: Wei-Chu Victoria Lai